Navigation Links
Navneet Tyagi Supports Continued Efforts for Alzheimer Detection Procedures
Date:6/20/2013

New York, New York (PRWEB) June 20, 2013

As a key researcher in the areas of protein folding and misfolding, Navneet Tyagi has remained closely linked to neurodegenerative diseases, including ALS and Alzheimer’s disease. Throughout the myriad of scientific research that Tyagi has participated in, he has held steady to his commitment of identifying early onset of these severe and mysterious neurological conditions. It is his hope that through early diagnosis, more medical researchers will be able to understand about the nature of conditions, such as Alzheimer’s, and potentially discover new avenues for progressive treatment or even a cure.

For this reason, Navneet Tyagi commends new developments of Alzheimer’s diagnostic procedures highlighted in a recent MSN article. The article focuses on an eye test that has been used in clinical setting to detect the presence of Alzheimer’s disease in patients. MSN explains, “A new study will trial an American-developed NeuroVision test aimed at detecting people at risk of developing Alzheimer's disease. Dr. Lance Macaulay from CSIRO said recent research showed Alzheimer's disease developed slowly.” According to Macaulay, up until recently it has only been understood that detection of Alzheimer’s disease is only possible when the condition has reached later stages in patients.

Fortunately, new advancements in eye scanning tests could help provide earlier detection of this condition. MSN reports, “…with a positron emission tomography (PET) scan, plaque build-up in the brain could be detected 17 years before symptoms appeared.” Even more importantly, if successful, the PET scan could be implemented as a non-invasive and affordable test to help identify those who may be developing Alzheimer’s disease. For Navneet Tyagi, earlier research opens up new opportunities for attempting new treatments.

“Since Alzheimer’s disease diagnoses usually come much later—once the condition has progressed—available treatments and their results are really hard to track and study, especially in terms of offering recovery or a cure to patients. With earlier detection, researchers may be able to implement new solutions and studies to see if there is a way to attack this neurodegenerative disease during its earlier phases.”

According to MSN, there are trials of how the PET scan may be used for diagnosing Alzheimer’s disease in patients. “It is very encouraging to see that medical researchers are thinking outside of the box to determine ways to understand the body as a whole and use different resources to determine the presence of other potential problems. For instance, doctors being able to detect neurological issues through a patient’s eye health. If this test does prove accurate, think of how many people could become aware of their Alzheimer’s development with a simple eye test, and thus, be able to receive treatment earlier on—it could even save their lives one day,” Navneet Tyagi concludes.

About:

Navneet Tyagi is a scientist and researcher who has worked extensively in the areas of protein folding and misfolding, and the roles of different molecular chaperones in neurodegenerative diseases like ALS, Parkinson’s, and Alzheimer’s. He also worked on the identification of early childhood onset neurodegenerative diseases. His previous findings on the sodium/D-glucose cotransporter protein have proven highly influential in the ongoing development of diabetes treatments. Tyagi was educated in India and received his PhD in Germany.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10851153.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study Supports Value of Sigmoidoscopy, an Alternative to Colonoscopy
2. Study supports urate protection against Parkinsons disease, hints at novel mechanism
3. Dietary fiber alters gut bacteria, supports gastrointestinal health
4. Narconon Louisiana Supports United Nations International Day Against Drug Abuse and Illicit Trafficking
5. NIDA supports development of combined anti-heroin and HIV vaccine
6. Little evidence supports autism treatment options in adolescents
7. $1.8 million grant supports investigation of psoriasis link to cardiovascular disease
8. John Templeton Foundation grant supports Princeton neuroscientists to study cognitive control
9. Human umbilical cord blood cell co-culture supports embryonic stem cell expansion
10. Study Supports Link Between Obesity, Cavities in Homeless Kids
11. Best Christmas Gift for 2012: Instant Stress Relief on CD! Relaxintuit.com’s Award-Winning Meditation CD Soothes Anxiety, Depression, Pain & Supports Deep, Healthy Sleep
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: